Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

142.57
-3.1400-2.15%
Pre-market: 142.19-0.3773-0.26%07:59 EDT
Volume:3.06M
Turnover:440.59M
Market Cap:272.02B
PE:21.55
High:145.50
Open:145.39
Low:142.56
Close:145.71
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.68
T/O Rate:0.17%
Dividend:4.67
Dividend Rate:3.27%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.55
PE(LYR):19.94

Loading ...

Novartis Stock (NVS) Sinks on Another Setback, Muscle-Wasting Disorder Drug Disappoints

TIPRANKS
·
Sep 08

Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks

Deep News
·
Sep 08

Novartis Might Need More Deals to Deliver Growth Ambitions

Dow Jones
·
Sep 08

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Dow Jones
·
Sep 08

Novartis AG Falls 13% in Pre-Market Trading, DM1 Drug Phase III Clinical Trial Fails to Meet Primary Endpoint

Market Focus
·
Sep 08

Novartis's Latest Trial Setback Sinks Stock

Dow Jones
·
Sep 08

Novartis Genetic Muscle Disorder Drug Fails Phase 3 Trial; Shares Drop Pre-Bell

MT Newswires Live
·
Sep 08

The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular

Bellwether Stocks Movement
·
Sep 08

United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Benzinga Earnings
·
Sep 08

Novartis's Latest Trial Failure is Second Pipeline Setback in a Row

Dow Jones
·
Sep 08

Movement Alert|Novartis AG Falls 4.16% Overnight, Phase III Heart Disease Drug Pelacarsen Fails Key Cardiovascular Trial

Market Focus
·
Sep 08

European Equities Remain Flat as Energy Gains Offset by Pharma Slump

Deep News
·
Sep 08

Novartis AG Falls Monday, Underperforms Market

Dow Jones
·
Sep 08

Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321

TIPRANKS
·
Sep 07

Citi sees limited immediate downside for Ionis after pelacarsen failure

TIPRANKS
·
Sep 07

BofA sees low single-digit percentage downside for Novartis on pelacarsen miss

TIPRANKS
·
Sep 07

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

Dow Jones
·
Sep 07

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Reuters
·
Sep 07

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Stock News
·
Sep 07

Novartis Heart-Trial Failure Could be Mitigated by Investor Caution

Dow Jones
·
Sep 07